Literature DB >> 15937017

Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.

B Galobardes1, G Davey Smith, M Jeffreys, S Kinra, P McCarron.   

Abstract

Androgen level or androgen activity is implicated in several health outcomes, but its independent role remains controversial. This study investigated the association between history of acne in young adulthood, a marker of hormone activity, and cause-specific mortality in the Glasgow Alumni Cohort Study. Male students who attended Glasgow University between 1948 and 1968 and participated in voluntary health checks reported history of acne (n = 11,232). Vital status has been traced, and risk factors in adulthood are known for about 50% of the participants. Those with a history of acne were more often nonsmokers while university students and tended to be from a lower socioeconomic position. The two groups did not differ in other adolescent (height, body mass index, blood pressure, and number of siblings) or in most adult risk factors. Students who reported a history of acne had a lower risk of all-cause (hazard ratio = 0.89, 95% confidence interval (CI): 0.76, 1.04) and coronary heart disease (hazard ratio = 0.67, 95% CI: 0.48, 0.94) mortality but had some evidence of a higher risk of prostate cancer mortality (hazard ratio = 1.67, 95% CI: 0.79, 3.55). This study shows that androgen activity during adolescence may protect against coronary heart disease but confer a higher risk of prostate cancer mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15937017     DOI: 10.1093/aje/kwi147

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

Review 1.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

2.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

Review 3.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.

Authors:  Debika Biswal Shinohara; Ajay M Vaghasia; Shu-Han Yu; Tim N Mak; Holger Brüggemann; William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian; Karen S Sfanos
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

5.  Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study.

Authors:  G Severi; B A Shannon; H N Hoang; L Baglietto; D R English; J L Hopper; J Pedersen; M C Southey; R Sinclair; R J Cohen; G G Giles
Journal:  Br J Cancer       Date:  2010-07-06       Impact factor: 7.640

6.  Acne and risk of prostate cancer.

Authors:  Siobhan Sutcliffe; Edward Giovannucci; William B Isaacs; Walter C Willett; Elizabeth A Platz
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

Review 7.  Prostate cancer: is it time to expand the research focus to early-life exposures?

Authors:  Siobhan Sutcliffe; Graham A Colditz
Journal:  Nat Rev Cancer       Date:  2013-01-31       Impact factor: 60.716

Review 8.  Not all acne is acne vulgaris.

Authors:  Harald P Gollnick; Christos C Zouboulis
Journal:  Dtsch Arztebl Int       Date:  2014-04-25       Impact factor: 5.594

9.  Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens.

Authors:  Tim N Mak; Shu-Han Yu; Angelo M De Marzo; Holger Brüggemann; Karen S Sfanos
Journal:  Prostate       Date:  2012-11-26       Impact factor: 4.104

10.  The association between irregular menstruations and acne with asthma and atopy phenotypes.

Authors:  Bruna Galobardes; Sumaiya Patel; John Henderson; Mona Jeffreys; George Davey Smith
Journal:  Am J Epidemiol       Date:  2012-09-30       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.